Evolving Paradigms in Squamous NSCLC: Conclusion

Evolving ParadigmsSquamous NSCLC
Volume 1
Issue 1

Squamous cell lung cancer represents a distinct molecular pathologic NSCLC with unmet therapeutic needs, especially after failure of first-line platinum-based doublet chemotherapy.

This article is Part III of a series. View parts I and II:Evolving Paradigms in Squamous NSCLC> >

Related Videos
Expert on NSCLC
Expert on NSCLC
Expert on NSCLC
Related Content